Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/245391
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Targeting the integrin interactome in human disease |
Autor: | Vicente-Manzanares, Miguel CSIC ORCID ; Sánchez-Madrid, Francisco | Fecha de publicación: | dic-2018 | Editor: | Elsevier | Citación: | Current Opinion in Cell Biology 55: 17-23 (2018) | Resumen: | Integrins comprise one of the most important families of cell–cell or cell–matrix adhesion receptors. Integrin interaction with their extracellular ligands is tunable by microenvironment signals, such as chemokines and growth factors, which modulate their interaction with other transmembrane proteins and cytoplasmic interactors. Integrins are important in different disease contexts, particularly inflammatory diseases and cancer. Clinical trials targeting integrins began in the early 2000s, leading to an increasingly clear picture: agents against integrins and their interactome control inflammatory diseases; whereas their efficacy as anti-cancer targets remains dubious. Here, we discuss the success of integrin targeting to treat autoimmunity and its failure in cancer, which is rooted in the plasticity and adaptability of the cancer cell. | Versión del editor: | http://dx.doi.org/10.1016/j.ceb.2018.05.010 | URI: | http://hdl.handle.net/10261/245391 | DOI: | 10.1016/j.ceb.2018.05.010 | ISSN: | 1879-0410 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
32
checked on 16-feb-2023
WEB OF SCIENCETM
Citations
31
checked on 05-mar-2023
Page view(s)
47
checked on 28-mar-2024
Download(s)
13
checked on 28-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.